Selection and use of anti-infective agents for intra-abdominal infections;Seleção e uso de antibióticos em infecções intra-abdominais

Arquivos de Gastroenterologia

Volumn 44, Issue 1, 2007, Pages 85-90

  Coelho, Júlio Cezar Uili ^a,b   Baretta, Giorgio Alfredo Pedroso ^a   Okawa, Luciano ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b Rua Bento Viana   (Brazil)

Author keywords

Abdomen; Anti bacterial agents; Cross infection; Infection

Indexed keywords

ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; ERTAPENEM; GATIFLOXACIN; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIMENTIN;

ABDOMINAL INFECTION; ANTIBIOTIC THERAPY; APPENDICITIS; ARTICLE; DIGESTIVE SYSTEM PERFORATION; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG SELECTIVITY; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; MONOTHERAPY; PANCREATITIS; TREATMENT DURATION; TREATMENT FAILURE;

EID: 34447538093     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/s0004-28032007000100018     Document Type: Article

References (32)

1. Aldridge KE, O'Brien M. In vitro susceptibilities of the Bacteroides fragilis group species: change in isolation rates significantly affects overall susceptibility data. J Clin Microbiol. 2002;40:4349-52.
2. Beger HG, Bittner R, Block S, Büchler M. Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology. 1986;91:433-8.
3. Berne TV, Yellin AW, Appleman MD, Heseltine PN. Antibiotic management of surgically treated gangrenous or perforated appendicitis: comparison of gentamicin and clindamycin versus cefamandole versus cefoperazone. Am J Surg. 1982;144: 8-13.
4. Bilik R, Burnweit C, Shandling B. Is abdominal cavity culture of any value in appendicitis? Am J Surg. 1998;175:267-70.
5. Boey J, Wong J, Ong GB. Bacteria and septic complications in patients with perforated duodenal ulcers. Am J Surg. 1982;143:635-9.
6. Bohnen JMA, Solomkin JS, Dellinger EP, Bjornson HS, Page CP. Guidelines for clinical care: anti-infective agents for intra-abdominal infection. A surgical infection society policy statement. Arch Surg. 1992;127:83-9.
7. Brook I. Intra-abdominal, retroperitoneal, and visceral abscesses in children. Eur J Pediatr Surg. 2004;14:265-73.
8. Cohn SM, Lipsett PA, Buchman TG, Cheadle WG, Milsom JW, O'Marro S, Yellin AE, Jungerwirth S, Rochefort EV, Haverstock DC, Kowalsky SF. Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intra-abdominal infections. Ann Surg. 2000;232:254-62.
9. Cruse JPE. Postoperative study of 20,105 surgical wounds with emphasis on the use of topical antibiotics and prophylactic antibiotics. Presentation at Fourth Symposium on Control of Surgical Infections, American College of Surgeons, Washington D.C. 10 November, 1972.
10. Dellinger EP, Wertz MJ, Meakins JL, Solomkin JS, Allo MD, Howard RJ, Simmons RL. Surgical infection stratification system for intra-abdominal infection. Multicenter trial. Arch Surg. 1985;120:21-9.
11. Falagas ME, Barefoot L, Griffith J, Ruthazar R, Snydman DR. Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections. Eur J Clin Microbiol Infect Dis. 1996;15:913-21.
12. FELAC - Federação Latino Americana de Cirurgia. Antimicrobianos: antibióticos profiláticos. In: FELAC. Ferida e infecção cirúrgica. Bogotá, Colômbia; 2001. p.287-300.
13. Ferraz EM, Ferraz AAB. Antibioticoprofilaxia. In: Ferraz EM, editor. Infecção em cirurgia. Rio de Janeiro: Medsi; 1997. p.345-52.
14. Fong IW. Septic complications of perforated peptic ulcer. Can J Surg. 1983;26:370-2.
15. Garg PK, Khanna S, Bohidar NP, Kapil A, Tandon RK. Incidence, spectrum and antibiotic sensitivity pattern of bacterial infections among patients with acute pancreatitis. J Gastroenterol Hepatol. 2001;16:1055-9.
16. Gleisner AL, Argenta R, Pimentel M, Simon TK, Jungblut CF, PetteffiL, de Souza RM, Sauerssig M, Kruel CD, Machado AR. Infective complications according to duration of antibiotic treatment in acute abdomen. Int J Infect Dis. 2004;8:155-62.
17. Gloor B, Schmidt O, Uhl W, Buchler NW. Prophylactic antibiotics and pancreatic necrosis. Curr Gastroenterol Rep. 2001;3:109-14.
18. Golub R, Siddiqi, Pohl D. Role of antibiotics in acute pancreatitis: a meta-analysis. J Gastrointest Surg. 1998;2:496-505.
19. Kish MA. Guide to development of practice guidelines. Clin Infect Dis. 2001;32:851-4.
20. Kokoska ER, Silen ML, Tracy TF, Dillon PA, Kennedy DJ, Cradock TV, Weber TR. The impact of intraoperative culture on treatment and outcome in children with perforated appendicitis. J Pediatr Surg. 1999;34:749-53.
21. Mazuski JE, Sawyer RG, Nathens AB, DiPiro JT, Schein M, Kudsk KA, Yowler C, Therapeutic Agents Committee of the Surgical Infections Society. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary. Surg Infect (Larchmt). 2002;3:161-73.
22. Mazuski JE, Sawyer RG, Nathens AB, DiPiro JT, Schein M, Kudsk KA, Yowler C, Therapeutic Agents Committee of the Surgical Infections Society. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations. Surg Infect (Larchmt). 2002;3:175-233.
23. Montravers P, Gauzit R, Muller C, Marmuse JP, Fichelle A, Desmonts JM. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intra-abdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis. 1996;23:486-94.
24. Oztoprak N, Cevik MA, Akinci E, Korkmaz M, Erbay A, Eren SS, Balaban N, Bodur H. Risk factors for ICU-acquired methicillin-resistant Staphylococcus aureus infections. Am J Infect Control. 2006;34:1-5.
25. Polk HC Jr, Lopez-Mayor JF. Postoperative wound infections: a prospective study of determinant factors and prevention. Surgery. 1969;66:97-103.
26. Rau B, Pralle U, Mayer JM, Beger HG. Role of ultrassonographically guide fine-needle aspiration cytology in the diagnosis of infected pancreatic necrosis. Br J Surg. 1998;85:179-84.
27. Sharma VK, Howden CW. Prophylactic antibiotic administration reduces sepsis and mortality in acute necrotizing pancreatitis: a meta-analysis. Pancreas. 2001;22:28-31.
28. Shlaes DM, Gerding DN, John JF, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE, Paul SM, Ruskin J, Tenover FC, Watanakunakorn C. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis. 1997;25:584-99.
29. Solomkin JS, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, DiPiro JT, Buchman T, Dellinger EP, Jernigan J, Gorbach S, Chow AW, Bartlett J. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis. 2003;37:997-1005.
30. Taylor E, Berjis A, Bosch T, Hoehne F, Ozaeta M. The efficacy of postoperative oral antibiotics in appendicitis: a randomized prospective double-blinded study. Am Surg. 2004;70:858-62.
31. Westphal JF, Brogard JM. Biliary tract infections: a guide to drug treatment. Drugs. 1999;57:81-91.
32. Wilson SE, Turpin RS, Hu XH, Sullivan E, Mansley EC, Ma L. Does initial choice of antimicrobial therapy affect length of stay for patients with complicated intra-abdominal infections? Am Surg. 2005;71:816-20.